Evaluation of Levels of Urea and Creatinine, Comorbidity and Socioeconomic Status in Diabetic Patients
Urea/Creatinine, Comorbidity & Socioeconomic Status in Diabetic Patients
Keywords:Nephropathy, Diabetes, Renal diseases, Hyperglycaemia, Frequency, Comorbidity
Nephropathy occurs in 10±40% of patients who have Type I (insulin-dependent) diabetes mellitus [1±3]. The development of diabetic nephropathy cannot be explained by poor glycaemic control alone. Objectives: To determine the frequency, association of diabetes with gender, correlation of diabetes duration with urea and creatinine, co morbidity, socioeconomic status renal disease in diabetic patients. Methods: The study was carried out in Mayo Hospital. A total of 100 patients were included in this study from 1st November 2019 to 31st January 2020. Blood samples were collected from diabetic people for chemical analysis to determine the protein and Urea Creatinine Ratio (UCR). RFTs was done to calculate the urea/creatinine values and their ratios. Statistical analysis was performed by using SPSS software version 13. Results: The ratio of male and female diabetic patients was 60:40. Mean age of male diabetic patients was 53.67 years and of female diabetic patients was 50.42 years. Frequency of renal diseases in diabetic patients was 55%. A significant p-value was obtained from the correlation of duration of diabetes (yrs) with urea and creatinine (mg%). Frequency of co-morbidity in all diabetic patients was measured and the highest frequency was of heart diseases. Conclusions: We conclude that diabetes is the single main and leading cause of renal diseases. It is clear that diabetic kidney disease is becoming a problem in Pakistan. As long as the duration of diabetes increases there will be more chances of renal disease so the proper diagnose at time and management is very necessary.
DeFronzo RA. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 1988 Jun; 37(6): 667-87. doi: 10.2337/diab.37.6.667.
McKenna MT, Michaud CM, Murray CJ, Marks JS. Assessing the burden of disease in the United States using disability-adjusted life years. American Journal of Preventive Medicine. 2005 Jun; 28(5): 415-23. doi: 10.1016/j.amepre.2005.02.009.
Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1994 Jan; 330(1): 15-8. doi: 10.1056/NEJM199401063300103.
Bethesda M. US Renal Data System: USRDS 2004 Annual Data Report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2004.
Bethesda M. US Renal Data System: USRDS 2005 Annual Data Report.: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2005.
Motala AA, Pirie FJ, Gouws E, Amod A, Omar MA. Microvascular complications in South African patients with long duration diabetes mellitus. South African Medical Journal. 2001 Nov; 91(11): 987-92.
Wanjohi FW, Otieno FC, Ogola EN, Amayo EO. Nephropathy in patients with recently diagonised type 2 diabetes mellitus in black Africans. East African Medical Journal. 2002 Aug; 79(8): 399-404. doi: 10.4314/eamj.v79i8.8824.
Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997 Jan; 40(2): 232-7. doi: 10.1007/s001250050668.
Simmons D, Schaumkel J, Cecil A, Scott DJ, Kenealy T. High impact of nephropathy on five‐year mortality rates among patients with Type 2 diabetes mellitus from a multi‐ethnic population in New Zealand. Diabetic Medicine. 1999 Nov; 16(11): 926-31. doi: 10.1046/j.1464-5491.1999.00187.x.
Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care. 1998 Apr; 21(4): 530-4. doi: 10.2337/diacare.21.4.530.
Wu AY, Kong NC, De Leon FA, Pan CY, Tai TY, Yeung VT, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the Microalbuminuria Prevalence (MAP) Study. Diabetologia. 2005 Jan; 48(1): 17-26. doi: 10.1007/s00125-004-1599-9.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes & Metabolism. 2001 Dec; 27(6): 628-34.
Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. American Journal of Epidemiology. 1988 Aug; 128(2): 389-401. doi: 10.1093/oxfordjournals.aje.a114979.
Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E, WHO Multinational Study Group. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetic Medicine. 1995 Feb; 12(2): 149-55. doi: 10.1111/j.1464-5491.1995.tb00446.x.
Fioretto P, Steffes MW, Brown DM, Mauer SM. An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. American Journal of Kidney Diseases. 1992 Dec; 20(6): 549-58. doi: 10.1016/S0272-6386(12)70217-2.
Adler S. Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney International. 2004 Nov; 66(5): 2095-106. doi: 10.1111/j.1523-1755.2004.00988.x.
Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2000 Jan; 23(1): 30-3. doi: 10.2337/diacare.23.1.30.
Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KA, Zoungas S, et al. Diabetic kidney disease. Nature Reviews Disease Primers. 2015 Jul; 1(1): 1-20. doi: 10.1038/nrdp.2015.70.
Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA. Prevalence of nondiabetic renal disease in diabetic patients. American Journal of Nephrology. 2007 May; 27(3): 322-8. doi: 10.1159/000102598.
Bamanikar SA, Bamanikar AA, Arora A. Study of Serum urea and Creatinine in Diabetic and nondiabetic patients in a tertiary teaching hospital. The Journal of Medical Research. 2016 Jan; 2(1): 12-5. doi: 10.31254/jmr.2016.2104.
How to Cite
Copyright (c) 2023 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments firstname.lastname@example.org